CEBUTID LP 200 mg, extended-release capsule 16 capsules
Active ingredients: (±)-flurbiprofen
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule16 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEBUTID LP 200 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène de 16 gélule(s)
- Marketing authorisation holder
- ALMIRALL (ESPAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jul 1990
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68411271CIP73319908CIP133400933199081Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLURBIPROFÈNEgélule | 200 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.